Innate Pharma SA NYSE EURONEXT - EURONEXT PARIS:IPHYF
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2025-12-31 · prior 2025-09-30.
New Positions(5)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 92,753 | +92,753 | $162.3K | +$162.3K | — |
| Lion Point Capital, LP | 81,151 | +81,151 | $142.0K | +$142.0K | — |
| OLD MISSION CAPITAL LLC | 28,431 | +28,431 | $49.8K | +$49.8K | — |
| MILLENNIUM MANAGEMENT LLC | 20,308 | +20,308 | $35.5K | +$35.5K | — |
| SageView Advisory Group, LLC | 1 | +1 | $2 | +$2 | — |
Added To(1)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | 5,204 | +4,734 | $9.1K | +$8.2K | 1007.2% |
Reduced(5)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| MORGAN STANLEY | 46,394 | -7,170 | $81.2K | -$22.2K | -13.4% |
| UBS Group AG | 947 | -3,850 | $1.7K | -$7.6K | -80.3% |
| GAMMA Investing LLC | 1,073 | -1,208 | $1.9K | -$2.5K | -53.0% |
| BARCLAYS PLC | 307 | 0 | $557 | -$36 | 0.0% |
| Farther Finance Advisors, LLC | 10 | 0 | $18 | -$1 | 0.0% |
Sold Out(3)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 0 | -20,042 | $0 | -$39.1K | — |
| Optiver Holding B.V. | 0 | -101 | $0 | -$197 | — |
| PRINCIPAL SECURITIES, INC. | 0 | -45 | $0 | -$87 | — |
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2025-12-31.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| JANE STREET GROUP, LLC | 92,753 | $162.3K | +92,753 | — |
| Lion Point Capital, LP | 81,151 | $142.0K | +81,151 | — |
| MORGAN STANLEY | 46,394 | $81.2K | -7,170 | -13.4% |
| OLD MISSION CAPITAL LLC | 28,431 | $49.8K | +28,431 | — |
| MILLENNIUM MANAGEMENT LLC | 20,308 | $35.5K | +20,308 | — |
| RHUMBLINE ADVISERS | 5,204 | $9.1K | +4,734 | 1007.2% |
| GAMMA Investing LLC | 1,073 | $1.9K | -1,208 | -53.0% |
| UBS Group AG | 947 | $1.7K | -3,850 | -80.3% |
| BARCLAYS PLC | 307 | $557 | 0 | 0.0% |
| Farther Finance Advisors, LLC | 10 | $18 | 0 | 0.0% |
| SageView Advisory Group, LLC | 1 | $2 | +1 | — |
New & Closed Positions this quarter
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for IPHYF against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.